Related Experiment Video
Updated: May 28, 2025
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics
Alia Ali Muhammad1, Manal Afzaal2, Mehak Joher Khan3
1Alia Ali Muhammad, FCPS Assistant Professor, Department of Medicine, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan.
Objective:
To determine the frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 diabetics.
Methods:
This cross-sectional study was conducted in Diabetic Clinic of Shaikh Zayed Postgraduate Medical Institute Lahore from January-October 2023. Type-2 diabetics regardless of age were evaluated by fasting lipid profile and were further evaluated by BMI, HbA1c and smoking. Exclusion criteria was patients taking lipid lowering drugs and all other causes of secondary dyslipidemias other than diabetes. Data for normally distributed quantitative variables was presented by Mean±SD, and for skewed measures were presented by using median (IQR). Dyslipidemia was described for each trait by using frequency and percentages.
Results:
A total of two hundred and twelve subjects were included in the study with the mean age of 53.4±9.1 years. About 96.6% patients were found to have different patterns of dyslipidemia that also showed positive association with smoking, uncontrolled HbA1c and obesity (p < 0.001).
Conclusion:
There is very high prevalence of dyslipidemia among Type-2 diabetics especially those who are smokers, with poor glycemic control and overweight/obese. Early screening of patients for dyslipidemia with lifestyle modifications and treatment of dyslipidemia can reduce risk of CVD.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:22Diabetes Mellitus: Type 2 and Gestational
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...